![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Demegen Licenses Compounds for Oral Diseases to Pacgen
Demegen Licenses Compounds for Oral Diseases to Pacgen
Demegen, Inc., a biotechnology company specializing in the development of peptides for the treatment of infectious diseases, announced it had granted a license to Pacgen Biopharmaceuticals Corporation for certain Demegen peptides for prescription and over-the-counter pharmaceutical products to treat oral diseases. Pacgen's initial focus will be a treatment for oral candidiasis, for which Demegen already has an approved IND.
PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/03-22-2005/0003239528&EDATE=)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct